175 related articles for article (PubMed ID: 36530960)
41. Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease.
Skrimizeas S; Dimeas IE; Dimeas G; Tzouvelekis A; Daniil Z
Cureus; 2023 Jul; 15(7):e42118. PubMed ID: 37602118
[TBL] [Abstract][Full Text] [Related]
42. [Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury].
Zhang PL; Yang HX; Zhang LN; Ge YP; Peng QL; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1055-1060. PubMed ID: 34916681
[TBL] [Abstract][Full Text] [Related]
43. Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
Endo Y; Koga T; Suzuki T; Hara K; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kuwana M; Kawakami A
Medicine (Baltimore); 2018 Apr; 97(15):e0436. PubMed ID: 29642214
[TBL] [Abstract][Full Text] [Related]
44. Clinically amyopathic dermatomyositis manifested after the allogeneic haematopoietic stem cell transplantation: Case presentation and literature review.
Miyagi R; Nakachi S; Tamaki Y; Doi M; Nakajima T; Kitamura S; Tomori S; Hanashiro T; Tamaki K; Morichika K; Nishi Y; Morishima S; Fukushima T; Masuzaki H
Mod Rheumatol Case Rep; 2023 Jan; 7(1):102-107. PubMed ID: 35950604
[TBL] [Abstract][Full Text] [Related]
45. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
Yamada K; Asai K; Okamoto A; Watanabe T; Kanazawa H; Ohata M; Ohsawa M; Hirata K
BMC Res Notes; 2018 Jan; 11(1):34. PubMed ID: 29338781
[TBL] [Abstract][Full Text] [Related]
46. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT
Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480
[TBL] [Abstract][Full Text] [Related]
47. Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation.
Al-Husayni F; Munshi A; Qanash S; Shaikhain TA; Alzahrani Z; Alghamdi B
Cureus; 2022 Aug; 14(8):e27839. PubMed ID: 36106216
[TBL] [Abstract][Full Text] [Related]
48. Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms.
Tamai K; Tachikawa R; Otsuka K; Ueda H; Hosono Y; Tomii K
Intern Med; 2014; 53(21):2515-9. PubMed ID: 25366013
[TBL] [Abstract][Full Text] [Related]
49. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
[TBL] [Abstract][Full Text] [Related]
50. Melanoma differentiation-associated gene 5 amyopathic dermatomyositis following an acute Mycoplasma pneumoniae infection: a case report.
Hoey J; Solomon JL; Kim B; Carsons S; Nusbaum J
J Med Case Rep; 2022 Nov; 16(1):401. PubMed ID: 36316755
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
Gil B; Merav L; Pnina L; Chagai G
Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
[TBL] [Abstract][Full Text] [Related]
52. Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.
Tsuji H; Nakashima R; Hosono Y; Imura Y; Yagita M; Yoshifuji H; Hirata S; Nojima T; Sugiyama E; Hatta K; Taguchi Y; Katayama M; Tanizawa K; Handa T; Uozumi R; Akizuki S; Murakami K; Hashimoto M; Tanaka M; Ohmura K; Mimori T
Arthritis Rheumatol; 2020 Mar; 72(3):488-498. PubMed ID: 31524333
[TBL] [Abstract][Full Text] [Related]
53. A case of anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease complicated with tracheobronchial ulcers.
Tsumiyama E; Yamakawa H; Sato S; Oba T; Nishizawa T; Kawabe R; Akasaka K; Amano M; Kamikawa T; Horikoshi M; Kuwano K; Matsushima H
Respir Med Case Rep; 2018; 25():189-191. PubMed ID: 30191123
[TBL] [Abstract][Full Text] [Related]
54. Mycophenolate mofetil for interstitial lung disease in dermatomyositis.
Morganroth PA; Kreider ME; Werth VP
Arthritis Care Res (Hoboken); 2010 Oct; 62(10):1496-501. PubMed ID: 20506189
[TBL] [Abstract][Full Text] [Related]
55. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
[TBL] [Abstract][Full Text] [Related]
56. A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil.
Muramatsu T; Tono T; Kanayama Y; Hasegawa Y; Kondo J; Hoshiyama T; Wada T; Arinuma Y; Tanaka S; Yamaoka K
Mod Rheumatol Case Rep; 2021 Jan; 5(1):69-75. PubMed ID: 32811369
[TBL] [Abstract][Full Text] [Related]
57. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
58. A case of sarcoidosis with interstitial lung disease mimicking clinically amyopathic dermatomyositis and rapidly progressive interstitial lung disease.
Sato S; Nogi S; Sasaki N; Chinen N; Honda K; Saito E; Wakabayashi T; Yamada C; Suzuki Y
Case Rep Rheumatol; 2014; 2014():195617. PubMed ID: 25431723
[TBL] [Abstract][Full Text] [Related]
59. The role of therapeutic plasma exchange in clinically amyopathic dermatomyositis with MDA-5 antibody: A case report and review of the literature.
Fine A; Karp JK; Peedin AR
J Clin Apher; 2020 Sep; 35(5):483-487. PubMed ID: 33617011
[TBL] [Abstract][Full Text] [Related]
60. Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis.
Teruya A; Kawamura K; Ichikado K; Sato S; Yasuda Y; Yoshioka M
Chest; 2013 Dec; 144(6):1934-1936. PubMed ID: 24297126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
